European  ||| S:0 E:9 ||| NNP
Diabetes  ||| S:9 E:18 ||| NNP
Working  ||| S:18 E:26 ||| NNP
Party  ||| S:26 E:32 ||| NNP
for  ||| S:32 E:36 ||| IN
Older  ||| S:36 E:42 ||| JJR
People  ||| S:42 E:49 ||| NNS
2011  ||| S:49 E:54 ||| CD
clinical  ||| S:54 E:63 ||| JJ
guidelines  ||| S:63 E:74 ||| NNS
for  ||| S:74 E:78 ||| IN
type  ||| S:78 E:83 ||| NN
2  ||| S:83 E:85 ||| CD
diabetes  ||| S:85 E:94 ||| NN
mellitus ||| S:94 E:102 ||| NN
.  ||| S:102 E:104 ||| .
Executive  ||| S:104 E:114 ||| JJ
summary  ||| S:114 E:122 ||| NN
The  ||| S:122 E:126 ||| DT
Clinical  ||| S:126 E:135 ||| JJ
Guidelines  ||| S:135 E:146 ||| NNS
provide  ||| S:146 E:154 ||| VBP
an  ||| S:154 E:157 ||| DT
opportunity  ||| S:157 E:169 ||| NN
to  ||| S:169 E:172 ||| TO
summarise  ||| S:172 E:182 ||| VB
the  ||| S:182 E:186 ||| DT
interpretation  ||| S:186 E:201 ||| NN
of  ||| S:201 E:204 ||| IN
relevant  ||| S:204 E:213 ||| JJ
clinical  ||| S:213 E:222 ||| JJ
trial  ||| S:222 E:228 ||| NN
evidence  ||| S:228 E:237 ||| NN
for  ||| S:237 E:241 ||| IN
older  ||| S:241 E:247 ||| JJR
people  ||| S:247 E:254 ||| NNS
with  ||| S:254 E:259 ||| IN
diabetes ||| S:259 E:267 ||| NN
.  ||| S:267 E:269 ||| .
They  ||| S:269 E:274 ||| PRP
are  ||| S:274 E:278 ||| VBP
intended  ||| S:278 E:287 ||| VBN
to  ||| S:287 E:290 ||| TO
support  ||| S:290 E:298 ||| VB
clinical  ||| S:298 E:307 ||| JJ
decisions  ||| S:307 E:317 ||| NNS
in  ||| S:317 E:320 ||| IN
older  ||| S:320 E:326 ||| JJR
people  ||| S:326 E:333 ||| NNS
with  ||| S:333 E:338 ||| IN
diabetes  ||| S:338 E:347 ||| NN
and  ||| S:347 E:351 ||| CC
the  ||| S:351 E:355 ||| DT
primary  ||| S:355 E:363 ||| JJ
focus  ||| S:363 E:369 ||| NN
is  ||| S:369 E:372 ||| VBZ
enhancing  ||| S:372 E:382 ||| VBG
high  ||| S:382 E:387 ||| JJ
quality  ||| S:387 E:395 ||| NN
diabetes  ||| S:395 E:404 ||| NN
care  ||| S:404 E:409 ||| NN
by  ||| S:409 E:412 ||| IN
the  ||| S:412 E:416 ||| DT
use  ||| S:416 E:420 ||| NN
of  ||| S:420 E:423 ||| IN
best  ||| S:423 E:428 ||| JJS
available  ||| S:428 E:438 ||| JJ
evidence ||| S:438 E:446 ||| NN
.  ||| S:446 E:448 ||| .
The  ||| S:448 E:452 ||| DT
principles  ||| S:452 E:463 ||| NNS
used  ||| S:463 E:468 ||| VBN
for  ||| S:468 E:472 ||| IN
developing  ||| S:472 E:483 ||| VBG
the  ||| S:483 E:487 ||| DT
recommendations  ||| S:487 E:503 ||| NNS
are  ||| S:503 E:507 ||| VBP
drawn  ||| S:507 E:513 ||| VBN
from  ||| S:513 E:518 ||| IN
the  ||| S:518 E:522 ||| DT
Scottish  ||| S:522 E:531 ||| NNP
Intercollegiate  ||| S:531 E:547 ||| NNP
Guidelines  ||| S:547 E:558 ||| NNP
Network  ||| S:558 E:566 ||| NNP
( ||| S:566 E:567 ||| -LRB-
SIGN ||| S:567 E:571 ||| NNP
)  ||| S:571 E:573 ||| -RRB-
based  ||| S:573 E:579 ||| VBN
in  ||| S:579 E:582 ||| IN
Edinburgh ||| S:582 E:591 ||| NNP
,  ||| S:591 E:593 ||| ,
Scotland ||| S:593 E:601 ||| NNP
.  ||| S:601 E:603 ||| .
Using  ||| S:603 E:609 ||| VBG
SIGN  ||| S:609 E:614 ||| NNP
50 ||| S:614 E:616 ||| CD
,  ||| S:616 E:618 ||| ,
the  ||| S:618 E:622 ||| DT
Guidelines  ||| S:622 E:633 ||| JJ
developer ||| S:633 E:642 ||| NN
's  ||| S:642 E:645 ||| POS
handbook ||| S:645 E:653 ||| NN
,  ||| S:653 E:655 ||| ,
each  ||| S:655 E:660 ||| DT
reviewer  ||| S:660 E:669 ||| NN
evaluated  ||| S:669 E:679 ||| VBD
relevant  ||| S:679 E:688 ||| JJ
and  ||| S:688 E:692 ||| CC
appropriate  ||| S:692 E:704 ||| JJ
studies  ||| S:704 E:712 ||| NNS
which  ||| S:712 E:718 ||| WDT
have  ||| S:718 E:723 ||| VBP
attempted  ||| S:723 E:733 ||| VBN
to  ||| S:733 E:736 ||| TO
answer  ||| S:736 E:743 ||| VB
key  ||| S:743 E:747 ||| JJ
clinical  ||| S:747 E:756 ||| JJ
questions  ||| S:756 E:766 ||| NNS
identified  ||| S:766 E:777 ||| VBN
by  ||| S:777 E:780 ||| IN
the  ||| S:780 E:784 ||| DT
Working  ||| S:784 E:792 ||| NNP
Party ||| S:792 E:797 ||| NNP
.  ||| S:797 E:799 ||| .
Searches  ||| S:799 E:808 ||| NNS
were  ||| S:808 E:813 ||| VBD
generally  ||| S:813 E:823 ||| RB
limited  ||| S:823 E:831 ||| VBN
to  ||| S:831 E:834 ||| TO
English  ||| S:834 E:842 ||| JJ
language  ||| S:842 E:851 ||| NN
citations  ||| S:851 E:861 ||| NNS
over  ||| S:861 E:866 ||| IN
the  ||| S:866 E:870 ||| DT
previous  ||| S:870 E:879 ||| JJ
15  ||| S:879 E:882 ||| CD
years  ||| S:882 E:888 ||| NNS
but  ||| S:888 E:892 ||| CC
the  ||| S:892 E:896 ||| DT
wide  ||| S:896 E:901 ||| JJ
experience  ||| S:901 E:912 ||| NN
and  ||| S:912 E:916 ||| CC
multinational  ||| S:916 E:930 ||| JJ
nature  ||| S:930 E:937 ||| NN
of  ||| S:937 E:940 ||| IN
the  ||| S:940 E:944 ||| DT
Working  ||| S:944 E:952 ||| JJ
party  ||| S:952 E:958 ||| NN
ensured  ||| S:958 E:966 ||| NN
that  ||| S:966 E:971 ||| IN
citations  ||| S:971 E:981 ||| NNS
in  ||| S:981 E:984 ||| IN
Italian ||| S:984 E:991 ||| JJ
,  ||| S:991 E:993 ||| ,
French  ||| S:993 E:1000 ||| NNP
Spanish ||| S:1000 E:1007 ||| NNP
,  ||| S:1007 E:1009 ||| ,
and  ||| S:1009 E:1013 ||| CC
German  ||| S:1013 E:1020 ||| NNP
were  ||| S:1020 E:1025 ||| VBD
considered  ||| S:1025 E:1036 ||| VBN
if  ||| S:1036 E:1039 ||| IN
relevant ||| S:1039 E:1047 ||| JJ
.  ||| S:1047 E:1049 ||| .
All  ||| S:1049 E:1053 ||| DT
relevant  ||| S:1053 E:1062 ||| JJ
published  ||| S:1062 E:1072 ||| JJ
articles  ||| S:1072 E:1081 ||| NNS
were  ||| S:1081 E:1086 ||| VBD
identified  ||| S:1086 E:1097 ||| VBN
from  ||| S:1097 E:1102 ||| IN
the  ||| S:1102 E:1106 ||| DT
following  ||| S:1106 E:1116 ||| JJ
databases ||| S:1116 E:1125 ||| NN
:  ||| S:1125 E:1127 ||| :
Embase ||| S:1127 E:1133 ||| NNP
,  ||| S:1133 E:1135 ||| ,
Medline ||| S:1135 E:1142 ||| NNP
/ ||| S:1142 E:1143 ||| NNP
PubMed ||| S:1143 E:1149 ||| NNP
,  ||| S:1149 E:1151 ||| ,
Cochrane  ||| S:1151 E:1160 ||| NNP
Trials  ||| S:1160 E:1167 ||| NNP
Register ||| S:1167 E:1175 ||| NNP
,  ||| S:1175 E:1177 ||| ,
Cinahl ||| S:1177 E:1183 ||| NNP
,  ||| S:1183 E:1185 ||| ,
and  ||| S:1185 E:1189 ||| CC
Science  ||| S:1189 E:1197 ||| NNP
Citation ||| S:1197 E:1205 ||| NNP
.  ||| S:1205 E:1207 ||| .
Hand  ||| S:1207 E:1212 ||| NN
searching  ||| S:1212 E:1222 ||| VBG
of  ||| S:1222 E:1225 ||| IN
13  ||| S:1225 E:1228 ||| CD
key  ||| S:1228 E:1232 ||| JJ
major  ||| S:1232 E:1238 ||| JJ
peer-reviewed  ||| S:1238 E:1252 ||| JJ
journals  ||| S:1252 E:1261 ||| NNS
was  ||| S:1261 E:1265 ||| VBD
undertaken  ||| S:1265 E:1276 ||| VBN
by  ||| S:1276 E:1279 ||| IN
two  ||| S:1279 E:1283 ||| CD
reviewers  ||| S:1283 E:1293 ||| NNS
and  ||| S:1293 E:1297 ||| CC
included  ||| S:1297 E:1306 ||| VBD
the  ||| S:1306 E:1310 ||| DT
Lancet ||| S:1310 E:1316 ||| NNP
,  ||| S:1316 E:1318 ||| ,
Diabetes ||| S:1318 E:1326 ||| NNP
,  ||| S:1326 E:1328 ||| ,
Diabetologia ||| S:1328 E:1340 ||| NNP
,  ||| S:1340 E:1342 ||| ,
Diabetes  ||| S:1342 E:1351 ||| NNP
Care ||| S:1351 E:1355 ||| NNP
,  ||| S:1355 E:1357 ||| ,
Diabetes  ||| S:1357 E:1366 ||| NNP
and  ||| S:1366 E:1370 ||| CC
Metabolism ||| S:1370 E:1380 ||| NNP
,  ||| S:1380 E:1382 ||| ,
British  ||| S:1382 E:1390 ||| NNP
Medical  ||| S:1390 E:1398 ||| NNP
Journal ||| S:1398 E:1405 ||| NNP
,  ||| S:1405 E:1407 ||| ,
New  ||| S:1407 E:1411 ||| NNP
England  ||| S:1411 E:1419 ||| NNP
Journal  ||| S:1419 E:1427 ||| NNP
of  ||| S:1427 E:1430 ||| IN
Medicine ||| S:1430 E:1438 ||| NNP
,  ||| S:1438 E:1440 ||| ,
and  ||| S:1440 E:1444 ||| CC
the  ||| S:1444 E:1448 ||| DT
Journal  ||| S:1448 E:1456 ||| NNP
of  ||| S:1456 E:1459 ||| IN
the  ||| S:1459 E:1463 ||| DT
American  ||| S:1463 E:1472 ||| NNP
Medical  ||| S:1472 E:1480 ||| NNP
Association ||| S:1480 E:1491 ||| NNP
.  ||| S:1491 E:1493 ||| .
Key  ||| S:1493 E:1497 ||| JJ
evidenced-based  ||| S:1497 E:1513 ||| JJ
recommendations  ||| S:1513 E:1529 ||| NNS
were  ||| S:1529 E:1534 ||| VBD
made  ||| S:1534 E:1539 ||| VBN
in  ||| S:1539 E:1542 ||| IN
18  ||| S:1542 E:1545 ||| CD
clinical  ||| S:1545 E:1554 ||| JJ
domains  ||| S:1554 E:1562 ||| NN
of  ||| S:1562 E:1565 ||| IN
interest  ||| S:1565 E:1574 ||| NN
and  ||| S:1574 E:1578 ||| CC
Good  ||| S:1578 E:1583 ||| NNP
Clinical  ||| S:1583 E:1592 ||| NNP
Practice  ||| S:1592 E:1601 ||| NNP
points  ||| S:1601 E:1608 ||| VBZ
identified ||| S:1608 E:1618 ||| VBN
.  ||| S:1618 E:1620 ||| .
A  ||| S:1620 E:1622 ||| DT
glucose-lowering  ||| S:1622 E:1639 ||| JJ
algorithm  ||| S:1639 E:1649 ||| NN
has  ||| S:1649 E:1653 ||| VBZ
been  ||| S:1653 E:1658 ||| VBN
provided  ||| S:1658 E:1667 ||| VBN
for  ||| S:1667 E:1671 ||| IN
frail  ||| S:1671 E:1677 ||| VBG
older  ||| S:1677 E:1683 ||| JJR
patients  ||| S:1683 E:1692 ||| NNS
with  ||| S:1692 E:1697 ||| IN
diabetes ||| S:1697 E:1705 ||| NN
.  ||| S:1705 E:1707 ||| .
We  ||| S:1707 E:1710 ||| PRP
have  ||| S:1710 E:1715 ||| VBP
provided  ||| S:1715 E:1724 ||| VBN
an  ||| S:1724 E:1727 ||| DT
up-to-date  ||| S:1727 E:1738 ||| JJ
evidenced-based  ||| S:1738 E:1754 ||| JJ
approach  ||| S:1754 E:1763 ||| NN
to  ||| S:1763 E:1766 ||| TO
practical  ||| S:1766 E:1776 ||| JJ
clinical  ||| S:1776 E:1785 ||| JJ
decision-making  ||| S:1785 E:1801 ||| NN
for  ||| S:1801 E:1805 ||| IN
older  ||| S:1805 E:1811 ||| JJR
adults  ||| S:1811 E:1818 ||| NNS
with  ||| S:1818 E:1823 ||| IN
type  ||| S:1823 E:1828 ||| NN
2  ||| S:1828 E:1830 ||| CD
diabetes  ||| S:1830 E:1839 ||| NN
of  ||| S:1839 E:1842 ||| IN
70  ||| S:1842 E:1845 ||| CD
years  ||| S:1845 E:1851 ||| NNS
and  ||| S:1851 E:1855 ||| CC
over ||| S:1855 E:1859 ||| RB
.  ||| S:1859 E:1861 ||| .
We  ||| S:1861 E:1864 ||| PRP
have  ||| S:1864 E:1869 ||| VBP
included  ||| S:1869 E:1878 ||| VBN
a  ||| S:1878 E:1880 ||| DT
user-friendly  ||| S:1880 E:1894 ||| JJ
set  ||| S:1894 E:1898 ||| NN
of  ||| S:1898 E:1901 ||| IN
recommendations  ||| S:1901 E:1917 ||| NNS
to  ||| S:1917 E:1920 ||| TO
aid  ||| S:1920 E:1924 ||| VB
clinical  ||| S:1924 E:1933 ||| JJ
decision-making  ||| S:1933 E:1949 ||| NN
in  ||| S:1949 E:1952 ||| IN
primary ||| S:1952 E:1959 ||| JJ
,  ||| S:1959 E:1961 ||| ,
community-based  ||| S:1961 E:1977 ||| JJ
and  ||| S:1977 E:1981 ||| CC
secondary  ||| S:1981 E:1991 ||| JJ
care  ||| S:1991 E:1996 ||| NN
settings ||| S:1996 E:2004 ||| NNS
.  ||| S:2004 E:2006 ||| .
